Tracking when private companies are nearing a sale, recap, or financing event has always been a guessing game. With thousands of sponsor-backed firms spread across sectors and geographies, most deal teams are forced to react after the market moves.
Investors, bankers, and service providers struggle to know which private companies are gearing up for a transaction or capital raise. Signals are scattered, opaque, and nearly impossible to track across thousands of PE- and VC-backed businesses.
Dakota centralizes those signals (holding periods, funding rounds, platform acquisition dates, ownership changes, and exit timing patterns) into one predictive transaction-readiness tool. Instead of waiting for headlines, users can see which companies are showing the strongest likelihood of pursuing a sale, recapitalization, or new financing before the market knows.
Below is today’s list of five PE- or VC-backed companies that, based on their hold period, financing stage, and last transaction date, appear to be credible candidates for a sale or next-round raise.
Nothing is guaranteed, but these companies fall squarely within the timing windows where sponsors typically look to generate liquidity or secure additional capital.
Sourced from Dakota Sponsor Backed Companies.
1. Venn
Venn is a Canadian fintech company specializing in providing comprehensive financial solutions tailored for businesses. Founded in 2021 by former Revolut employees Ahmed Shafik and Saud Aziz, Venn aims to simplify business banking by offering a unified platform that integrates global accounts, spend management, foreign exchange services, transfers, and accounting automation. The company is headquartered in Toronto, Ontario, Canada, and has onboarded over 4,000 businesses since its launch in 2023. Venn's mission is to empower Canadian businesses with modern financial tools that streamline operations and foster growth.
- Sector: Fintech
- Industry: Business Banking
- Last known transaction date: $21.5 M Series A February 2025
- Major sponsors/backers: Left Lane Capital (lead), XYZ Venture Capital, Intact Ventures, Gradient
- Why timing suggests a near-term transaction: Venn has completed a meaningful rebrand from Vault and raised a $21.5M Series A to accelerate platform expansion beyond multi-currency accounts into a full-stack business banking solution (global accounts, spend management, FX, transfers, and accounting automation). The company is moving upmarket from SMBs toward more complex customers, signaling a push for scale and category consolidation. Given rising competitive pressure from both fintechs and incumbent banks, along with increasing M&A appetite for proven business-banking platforms in Canada, Venn could emerge as an attractive acquisition target for a larger financial institution or global fintech seeking Canadian market entry or expansion.
View all private company data in Dakota Marketplace.
2. QMe
QMe Solutions is an Egyptian B2B SaaS startup founded in 2022 by Maged Negm. The company specializes in AI-based digital queuing solutions, aiming to eliminate long waiting times in various sectors such as healthcare, banking, and government. Their platform integrates booking, queuing, analytics, and payment solutions into a unified infrastructure, enhancing customer experience by reducing waiting times and improving service efficiency. Since its commercial launch in Q4 2023, QMe has served over 100,000 customers, reducing average waiting times from 116 minutes to just 14 minutes. The company is headquartered in Cairo, Egypt
- Sector: Information Technology
- Industry: Software
- Last known transaction date: Seed, $3M announced in February 2025
- Major sponsors/backers: Led by AHOY
- Why timing suggests a near-term transaction: QMe’s $3M seed round announced in February 2025 places the company approximately 12–18 months removed from its initial financing by mid to late 2026. At this stage, venture-backed platforms often begin preparing for a follow-on growth round, strategic partnerships, or early acquisition discussions, as product development milestones are reached and early customer traction becomes clearer.
View all private company data in Dakota Marketplace.
3. SimCare AI
SimCare AI is a healthcare technology company founded in 2024 by Vrishank Saini and Tiko Bdoyan. Headquartered in San Francisco, California, the company specializes in utilizing artificial intelligence to enhance clinical training. Their primary product is a platform offering AI-driven simulations that allow healthcare professionals to practice counseling skills with virtual clients. This approach aims to streamline training processes, reduce costs, and improve patient care by providing realistic, interactive scenarios for clinicians. As of December 2025, SimCare AI has trained over 15,000 students and collaborates with more than 70 educational programs to integrate their simulations into counseling curricula.
- Sector: Healthcare Technology / Digital Health
- Industry: Clinical training & medical simulation software (AI-enabled)
- Last known funding round: Seed round, $2M announced February 2025
- Major sponsors/backers: Y Combinator (lead), Drive Capital (lead), Harper Court Ventures Fund, Singularity Capital, Triple S Ventures, Goodwater Capital, Asymmetry Ventures, Sand Hill North, Transpose Platform
- Why timing suggests a near-term transaction: SimCare AI’s $2M seed round in early 2025 positions the company in the typical 12–18 month window where venture-backed healthcare software startups begin pursuing a Series A, strategic partnerships, or early acquisition discussions. With meaningful early adoption across academic and training institutions, strong outcome metrics, and growing demand driven by clinician shortages and training bottlenecks, SimCare AI could attract interest from healthcare education platforms, medical simulation companies, or larger health IT vendors seeking AI-native training capabilities.
View all private company data in Dakota Marketplace.
4. Freed
Freed is an AI-powered medical scribe platform designed to reduce administrative burden for clinicians. It listens to patient visits, transcribes medical conversations, and generates specialty-aware clinical notes that can be reviewed and pushed to EHR systems. Freed emphasizes accuracy, ease of use, and data security (HIPAA, SOC2, HITECH) while adapting to each clinician’s style and workflow.
- Sector: Healthcare Technology / Digital Health
- Industry: Clinical documentation automation / AI medical scribe software
- Last known funding round: Series A, $30M announced March 2025
- Major sponsors/backers: Sequoia Capital (lead), Scale Venture Partners, Daniel Gross, Gokul Rajaram, Ted Zagat
- Why timing suggests a near-term transaction: Freed’s $30M Series A in early 2025 follows rapid commercial adoption and positions the company in a typical 18–24 month window for either a growth-stage financing or strategic acquisition. With strong revenue traction, expanding functionality beyond note-taking into a broader AI clinician assistant, and intense M&A interest from EHR vendors, healthcare IT platforms, and payer-adjacent software providers seeking workflow automation, Freed could attract strategic interest as it scales further into enterprise healthcare systems.
View all private company data in Dakota Marketplace.
5. Salvus Health
Salvus Health is a digital health company based in Antwerp, Belgium, founded in 2020 by Salvador Severich. The company aims to empower individuals to take control of their health by making medical innovations more accessible. Salvus Health offers a comprehensive platform designed to enhance patient engagement and streamline pharmacy operations. Their services include vaccination management, medication consultations, dispensing support, health checks, and risk assessments. The platform integrates patient relationship management tools, scheduling, communication, and care coordination features to support pharmacies in delivering personalized care.
- Sector: Information Technology
- Industry: Software
- Last known funding round: Seed, $525K announced March 2025
- Major sponsors/backers: Participation from Angelwise
- Why timing suggests a near-term transaction: Salvus Health’s $525K seed round announced in March 2025 places the company approximately 12–18 months removed from its initial financing by mid to late 2026. At this stage, venture-backed healthcare startups often begin preparing for a follow-on funding round, strategic partnerships, or early acquisition discussions, as product validation, pilot programs, and early customer engagement progress.
View all private company data in Dakota Marketplace.
Use Dakota’s Sponsor Backed Company Intelligence to Spot Likely Exits Before the Market Does
Dakota’s private company data gives you a real-time view into thousands of sponsor-backed companies, including platform acquisition dates, funding rounds, parent sponsors, add-on activity, and sector categorization.
Instead of guessing where companies are in their lifecycle, you can instantly identify which ones are approaching the typical timing windows for a sale or recap.
Fully integrated into Dakota Marketplace, this dataset enables deal sourcers, investor relations teams, and allocators to anticipate transactions, build targeted outreach lists, and stay ahead of market announcements, every single day.
To explore more companies likely to transact, book a demo of Dakota Marketplace!
